Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Recombinant-molecule-encoding-human-protease-nexin

 Methods of inhibiting GPR-9-6 function
The invention relates to an antibody (immunoglobulin) or functional fragment thereof (e.g., an ...


 Method for cloning of a rare, specifically mutated cell
The invention is a new and improved method for reliably detecting the presence of a rare cell ...


 Vaccine against Gram-negative bacterial infections
OF THE PREFERRED EMBODIMENTS According to the present invention, a non-covalent, polyvalent ...


 Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin
The present invention relates to modified .beta.-chains of human hemoglobin having an oxygen ...


 Inhibitor of stem cell proliferation and uses thereof
The present invention relates to polypeptides which are inhibitors of stem cell proliferation ("INPR...


 Inhibitor of stem cell proliferation and uses thereof
The present invention relates to an inhibitor of stem cell proliferation (INPROL) characterized by ...


 Method of inhibiting angiogenesis using secreted proteins
Isolated Proteins Nucleotide and amino acid sequences, as presently determined, are reported below ...


 Balanced extraction system
The present invention is a device wherein matter to be extracted which contains various available ...


 Compounds for the treatment of hepatoma
What is claimed is: 1. The method of treatment of a living subject affected by hepatoma which ...


 5ht2 agonists for controlling IOP and treating glaucoma
1. A method for lowering or controlling intraocular pressure or treating glaucoma which comprises ...


 Recombinant molecule encoding human protease nexin

Details
Inventors: Baker, Joffre B.; Scott, Randy W.;
Assignee: Incyte Pharmaceuticals, Inc. (Redwood City, CA)
Primary Examiner: Ellis; Joan
Assistant Examiner:
Attorney, Agent or Firm: Bozicevic; Karl, Murashige; Kate H.

DNA segments encoding two slightly different protease nexin I forms (PN-I.alpha. and PN-I.beta.) are cloned and expressed to provide practical quantities of PN-I for diagnostic and therapeutic use. PN-I is a serine protease inhibitor useful in controlling conditions mediated by proteolytic activity.

DETAILED DESCRIPTION We claim: 1.
An isolated DNA molecule which encodes mature protease nexin-I (PN-I) alpha of FIG.
3 or PN-I beta of FIG.
4 or encodes a PN-I protein encoded by a gene which is a naturally occurring allelic variant of the gene encoding PN-I alpha or PN-I beta.
2.
The DNA molecule of claim 1 which further includes DNA encoding a signal sequence which is operably linked to said mature PN-1.
alpha.
or PN-1.
beta.
.
3.
The DNA molecule of claim 2 wherein the linked DNA encodes the signal sequence of mature human PN-I.
4.
A probe which is capable of hybridizing to mammalian cDNA that encodes PN-I and which is selected from the group consisting of (1) the Sau3AI fragment of PN-18; (2) the 750 bp EcoRI-Bg1II fragment of PN-18; (3) the 14-mer of FIG.
1a; and (4) the 36-mer of FIG.
1b.
5.
An expression vector comprising a DNA encoding a protease nexin I (PN-I) having the amino acid sequence of PN-I alpha of FIG.
3 or PN-I beta of FIG.
4, or having an amino acid sequence encoded by a gene which is a naturally occurring allelic variant of that encoding said PN-I alpha or PN-I beta wherein said expression vector is capable, when transformed into a host cell, of expressing said PN-I encoding DNA.
6.
The expression vector of claim 5 wherein the PN-I encoding DNA includes DNA encoding an operably linked signal sequence.
7.
A unicellular host cell transformed with the expression vector of claim 5.
8.
The host cell of claim 7 wherein said host cell is a mammalian cell and wherein said vector comprises an SV40-derived promoter.
9.
A method of producing PN-I alpha or PN-I beta which comprises culturing cells transformed with the expression system of claim 5 under conditions which induce the expression of said PN-I encoding DNA and recovering the PN-I protein produced.




Description:
TECHNICAL FIELD The invention relates to recombinant production of proteins affecting the cardiovascular system.
In particular, it concerns the cloning and expression of genes encoding forms of protease nexin I (PN-I)



Related patents
  Method for design of substances that enhance memory and improve the quality of life
I claim: 1. Each of the compounds Gln Phe Phe-.gamma.-aminobutyric acid (SEQ ID NO: 20) Gln Phe Phe-.beta.-alanine (SEQ ID NO: 21) Gln Phe Phe-.delta.-aminovaleric acid (...
  Amyloid .beta. protein (globular assembly and uses thereof)
What is claimed is: 1. An isolated, soluble, non-fibrillar amyloid .beta. protein assembly comprising 3-12 amyloid .beta. proteins, wherein the amyloid .beta. protein is ...
  Chlamydia antigens and corresponding DNA fragments and uses thereof
The present invention provides purified and isolated polynucleotide molecules that encode the Chlamydia polypeptide designated 76 kDa protein (SEQ ID No: 1) which can be ...
  Methods of treating inflammatory bowel disease using cholera toxin B subunit
What is claimed is: 1. A method of treating inflammatory bowel disease in a subject diagnosed with inflammatory bowel disease, comprising administering to the subject a ...
  Mammalian haemoglobin compatible with blood plasma, cross-linked and conjugated with polyalkylene oxides as artificial medical oxygen carriers, production and use thereof
1. Hemoglobin derivative compatible with human and non-human animal plasma, comprising hemoglobin crosslinked by means of a crosslinker for proteins and a polyalkylene ...
  Anti hepatitis C virus antibody and uses thereof
OF THE PRESENT INVENTION Accordingly, the technical problem of the invention is to provide means and methods for the treatment and prevention of HCV infection in humans....
  Chemical and/or biological decontamination system
OF THE INVENTION The present invention provides a composition that is effective in the decontamination of chemical agents and/or biological pathogens. The biological ...
  Immunostimulant bacterial membrane fractions in cancer treatment
The invention claimed is: 1. A method of stimulating an immune response and/or inducing an antitumor immune response in a mammal, including a human, in need thereof, ...
  Cloning and characterization of a human adenylyl cyclase
One aspect of the invention is an isolated and purified human type VI adenylyl cyclase (hAC6) polypeptide comprising the amino acid sequence of FIG. 1 (SEQ ID NO:2). A...
  Tumor antigen based on products of the tumor suppressor gene WT1
What is claimed is: 1. An isolated polypeptide which consists of at most 12 contiguous amino acid residues of a human WT1 protein, wherein the polypeptide comprises SEQ I...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved